Bioqual, Inc. BIOQ
31.00 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
31.00 Day range 31.00
30.64 52-week range 40.00
- YTD
- -19.50%
- 1 year
- -22.50%
- Market cap
- 27.73M
- EPS (ttm)
- 2.62
- P/E ratio
- 11.83
- YTD return
- -19.50%
- 1-year return
- -22.50%
- Volume
- 100
- Avg volume
- 34
- Open
- 31.00
- Previous close
- 31.00
- Day's range
- 31.00 – 31.00
- 52-week range
- 30.64 – 40.00
1M -2.00 (-6.06%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 22, 2024 | Aug 1, 2024 | 0.00 | -0.76 | — | — |
| Sep 20, 2024 | May 1, 2024 | 0.00 | -1.32 | — | — |
| Apr 22, 2024 | Feb 1, 2024 | 0.00 | 0.31 | — | — |
| Jan 23, 2024 | Nov 1, 2023 | 0.00 | 0.54 | — | — |
| Oct 20, 2023 | Aug 1, 2023 | 0.00 | 1.01 | — | — |
| Sep 20, 2023 | May 1, 2023 | 0.00 | -0.79 | — | — |
News
BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2027 
CORRECTING and REPLACING BIOQUAL Presents Financial Results for Fiscal Year 2026 
BIOQUAL Presents Financial Results for Fiscal Year 2026 
BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2026 
Reviewing Bioqual (OTCMKTS:BIOQ) and Option Care Health (NASDAQ:OPCH) 
BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2026 
Financial Analysis: Encompass Health (NYSE:EHC) vs. Bioqual (OTCMKTS:BIOQ) 
BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2026 
BIOQUAL Presents Financial Results for Fiscal Year 2025 
BIOQUAL Announces the retirement of Dr. Mark G. Lewis as President and CEO of the company
Your note
Sign in to keep a note on BIOQ — it syncs with the Stock Master app.